REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/12/2026
Back to search
Official data from USPTO
CURE RARE DISEASE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
01/13/2026
Trademark type
Combined
Nice classes
36
Filing date
12/09/2019
Registration date
01/12/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/12/2021
Last transaction
01/13/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2019-04-00
First use in commerce
2019-04-00
Drawing code
3
Owner type
99
Owner location
Boston, MA
Examiner
ROACH,APRIL K
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a solid semi-circle stylistically representing a rising sun partially obscured by a curved building with windows and a curved line below the building. The word "CURE" in all capital letters appears below the curved line, and the words "RARE DISEASE" in all capital letters appear below the word "CURE".
Holders and representatives
Holders
Cure Rare Disease, Inc.
Representatives
Jana E. Harris GREENBERG TRAURIG, LLP
Technical classification
Nice Classes
Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Charitable fundraising services
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/12/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/27/2020
PUBO
PUBLISHED FOR OPPOSITION
10/27/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/07/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/21/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/17/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/17/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/17/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/14/2020
GNFR
FINAL REFUSAL E-MAILED
09/14/2020
CNFR
FINAL REFUSAL WRITTEN
09/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/08/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/08/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/10/2020
GNRT
NON-FINAL ACTION E-MAILED
03/10/2020
CNRT
NON-FINAL ACTION WRITTEN
03/10/2020
DOCK
ASSIGNED TO EXAMINER
03/10/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/13/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/12/2019
NWAP
NEW APPLICATION ENTERED
12/12/2019
Continuous trademark protection
Get notified about every new filing that threatens CURE RARE DISEASE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.